Glycemic management in living donor liver transplantation for patients with glycogen storage disease type 1b

Pediatric Transplantation

Volumn 16, Issue 5, 2012, Pages 465-470

  Karaki, Chiaki ^a   Kasahara, Mureo ^a   Sakamoto, Seisuke ^a   Shigeta, Takanobu ^a   Uchida, Hajime ^a   Kanazawa, Hiroyuki ^a   Kakiuchi, Toshihiko ^a   Fukuda, Akinari ^a   Nakazawa, Atsuko ^a   Horikawa, Reiko ^a   Suzuki, Yasuyuki ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

anesthetic management; blood glucose management; glycogen storage disease 1b; liver transplantation; living donor liver transplantation

Indexed keywords

GLUCOSE;

BILE DUCT ATRESIA; CHILD; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 1B; HUMAN; HYPOGLYCEMIA; INCIDENCE; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PREOPERATIVE PERIOD; PRESCHOOL CHILD; QUALITY OF LIFE; REVIEW; SCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; HYPOGLYCEMIA; INFANT; INTRAOPERATIVE COMPLICATIONS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84863725491     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01705.x     Document Type: Review

References (20)

1. Cori GT, Cori CT,. Glucose-6-phosohatase in the liver glycogen storage diseases. J Bio Chem 1992: 199: 661-667.
2. Chen YT, Bruchell A,. Glycoge storage diseases. In:, Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 8th edn. New York: McGraw-Hill, 2011: pp. 1521-1551.
3. Kure S, Suzuki Y, Matsubara Y, et al., Molecular analysis of glycogen storage disease type 1b: Identification of a prevalent mutation among Japanese patients and assignment of putative glucose-6-phosphate translocase gene to chromosome 11. Biochem Biophys Res Commun 1998: 248: 426-431.
4. Frenandes J, Smit GPA,. The glycogen storage diseases. In:, Fernandes J, Sauduray JM, Berghd G, eds. Inborn metabolic disease, 3rd edn. New York: Springer, 2000: pp. 85-101.
5. Gitzelmann R, Bosshard NU,. Defective neutrophil and monocyte functions in glycogen storage disease type 1b: A literature review. Eur J Pediatr 1993: 152: S33-S38.
6. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GPA,. Glycogen storage disease type 1: Diagnosis, management, clinical course and outcome, Results of the European Study on Glycogen Storage Disease Type 1 (ESGSD1). Eur J Pediatr 2002: 161: S20-S30.
7. Lachaux A, Boillot O, Stamm D, et al., Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type 1b. J Pediatr 1993: 123: 1005-1008.
8. Toda S, Starzl TE, Tzakis A, et al., Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 1992: 15: 419-422.
9. Tanaka K, Uemoto S, Tokunaga Y, et al., Surgical techniques and innovations in living related liver transplantation. Ann Surg 1993: 217: 82-91.
10. Cox JM,. Anesthesia and glycogen-storage disease. Anesthesiology 1968: 29: 1221-1225.
11. Van Den Berghe G, Wilmer A, Hermans G, et al., Intensive insulin therapy in the medical ICU. N Engl J Med 2006: 354: 449-461.
12. Vlasselaers D, Milants I, Desmet L, et al., Intensive insulin therapy for patients in pediatric intensive care: A prospective, randomized controlled study. Lancet 2009: 373: 547-556.
13. Hanto WH, Fecteau AH, Alonso MH, Valente JF, Whiting JF,. ABO-imcompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: Evidence for accommodation. Liver Transpl 2003: 9: 22-30.
14. Shenkman Z, Golub Y, Meretyk S, Shir Y, Landau D, Landau EH,. Anaesthetic management of a patient with glycogen storage disease type 1b. Can J Anesth 1996: 43: 467-470.
15. Bezinover D, Kadry Z, McCullough P, et al., Release of cytokines and hemodynamic instability during the reperfusion of a liver graft. Liver Transpl 2011: 17: 324-330.
16. Ghafaripour S, Sahmeddini MA, Lahsaee SM, et al., Hypotension after reperfusion in liver transplantation: Histidine-tryptophan-ketoglutarate versus university of Wisconsin solution. Prog Transplant 2010: 20: 256-261.
17. Lemasters JJ,. Hypoxic, ischemic, and reperfusion injury to liver. In:, Arias IM, Boyer JL, Chisari FV, Fausto N, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathology, 4th edn. Philadelphia, PA: Lippincott Williams and Wilkins, 2001: pp. 257-279.
18. Kawasaki T, Ogata M, Kawasaki C, Tomihisa T, Okamoto K, Shigematus A,. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth Analg 2001: 92: 1322-1326.
19. Santos G, Jorge R, Francisco R, et al., Infection and associates risk factors in the immediate postoperative period of pediatric liver transplantation: A study of 176 transplants. Clin Transplant 1988: 12: 190-197.
20. Kasahara M, Horikawa R, Sakamoto S, et al., Living donor liver transplantation for glycogen storage disease type 1b. Liver Transpl 2009: 15: 1867-1871.